Awareness of mental health problems in patients with coronavirus disease 19 (COVID-19): A lesson from an adult man attempting suicide

Liu, Yong; Cao, Lin; Li, Xiaojin; Jia, Yingdong; Xia, Hongtao

doi:10.1016/j.ajp.2020.102106

Cited by 33 publications

(29 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…127 Fear relating to the disease due to poor knowledge 128 or misinformation 13 regarding to COVID-19, feeling of self-blame, 129 and social stigma 130,131 may also facilitate the development of psychiatric disorders in COVID-19 patients. In severe cases, COVID-19 patients had demonstrated suicidal and selfdestructive tendencies, 132,133 which highlights the importance of early detection and intervention for mental health problems in this population. Hospitals should implement remote mental health screening programs and psychiatric consultations using technologies, such as telemedicine and internetbased mental health interventions, 134,135 along with establishing a system allowing proper communication between hospitalized/quarantined patients and their families.…”

Section: Discussionmentioning

confidence: 98%

The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis

Deng

Zhou

Hou

et al. 2020

Annals of the New York Academy of Sciences

610

499

View full text Add to dashboard Cite

Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID-19 patients, we conducted a systematic review and randomeffects meta-analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37-54%, I 2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37-57%, I 2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19-50%, I 2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID-19 outpatients and COVID-19 patients from countries other than China are needed to further examine the psychological implications of COVID-19 infections.

show abstract

Section: Discussionmentioning

confidence: 98%

The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis

Deng

Zhou

Hou

et al. 2020

Annals of the New York Academy of Sciences

610

499

View full text Add to dashboard Cite

show abstract

“…The results also indicated that the prevalence of depression during the COVID-19 pandemic is almost identical to that during the SARS epidemic (11.9% vs 18.0%) among the general public in China [ 59 , 60 ]. Most of the research on mental disorders during public health emergencies in China focuses on the psychological status of patients or health care workers; depression in the general public is neglected and untreated [ 61 - 64 ]. The general public are extremely vulnerable to symptoms of depression during the COVID-19 pandemic.…”

Section: Discussionmentioning

confidence: 99%

Depression and Psychological-Behavioral Responses Among the General Public in China During the Early Stages of the COVID-19 Pandemic: Survey Study

Zhang¹,

Yang²,

Zhao³

et al. 2020

J Med Internet Res

View full text Add to dashboard Cite

Background The COVID-19 pandemic has recently spread dramatically worldwide, raising considerable concerns and resulting in detrimental effects on the psychological health of people who are vulnerable to the disease. Therefore, assessment of depression in members of the general public and their psychological and behavioral responses is essential for the maintenance of health. Objective This study aimed to assess the prevalence of depression and the associated factors among the general public during the early stages of the COVID-19 pandemic in China. Methods A cross-sectional survey with convenience sampling was conducted from February 11 to 16, 2020, in the early stages of the COVID-19 outbreak in China. A self-administrated smartphone questionnaire based on the Patient Health Questionnaire-9 (PHQ-9) and psychological and behavioral responses was distributed to the general public. Hierarchical multiple regression analysis and multivariate logistic regression analysis were conducted to explore the associated factors of depression.aA cross-sectional survey with convenience sampling was conducted from February 11 to 16, 2020, in the early stages of the COVID-19 outbreak in China. A self-administrated smartphone questionnaire based on the Patient Health Questionnaire-9 (PHQ-9) and psychological and behavioral responses was distributed to the general public. Hierarchical multiple regression analysis and multivariate logistic regression analysis were conducted to explore the associated factors of depression. Results The prevalence of depression (PHQ-9 score ≥10) among the general public during the COVID-19 pandemic was 182/1342 (13.6%). Regression analysis indicated that feeling stressed, feeling helpless, persistently being worried even with support, never feeling clean after disinfecting, scrubbing hands and items repeatedly, hoarding food, medicine, or daily supplies, and being distracted from work or study were positively associated with depression, while social support and being calm were negatively associated with depression. Conclusions The general public suffered from high levels of depression during the early stages of the COVID-19 pandemic. Thus, COVID-19–related mood management and social support should be provided to attenuate depression in the general public.

show abstract

“…In the early period of COVID‐19 pandemic, a top emergency room doctor at Manhattan Hospital and the Finance Minister of Germany committed suicide while participating in the anti‐pandemic work, 4,5 thereby eliciting people's concern about suicide risk and prevention during this crisis. Individuals were not only under unprecedented psychological pressure but also forced to suffer stigma and discrimination when being directly exposed to COVID‐19 virus or bereaved family in this bio‐disaster, associated with a higher suicide risk 8–10 . Besides, many studies indicated that children, adolescents, and older adults were the vulnerable populations that might be associated with a higher risk of suicide during the pandemic of infectious disease 11–17 .…”

mentioning

confidence: 99%

Raising awareness of suicide prevention during the COVID‐19 pandemic

Que

Yuan

Gong

et al. 2020

Neuropsychopharm Rep

View full text Add to dashboard Cite

Suicide is one of the top 20 leading causes of death worldwide. With the rapid spreading of coronavirus disease 2019 (COVID‐19) crisis around the world, suicide cases induced by the COVID‐19 pandemic have been reported in many countries. Individuals with suspected and confirmed COVID‐19 infection, frontline healthcare workers, bereaved families, elders, children, and adolescents are vulnerable populations who might be at elevated suicide risk. In this micro‐review, a systematic search through PubMed was performed for a comprehensive investigation of suicide risk factors during the pandemic. On this basis, we put forward considerations and advice for preventing pandemic related suicide, including staying socially connected through online platform or apps during period of quarantine, reducing unemployment, dispelling rumors and misinformation in time, and maintaining evidenced‐based management of psychiatric symptoms. More importantly, early detection and timely intervention of individuals with psychiatric disorders and suicide behaviors will be effective to reduce the number of suicides, with specific measurements of using validated scales to perform regular suicide risk screening, improving the availability of mental health services, and providing appropriate and evidence‐based interventions for individuals in demand. Policy makers, psychiatrists, psychologists, and other healthcare professionals need to collaborate to control the possible suicide events during the COVID‐19 pandemic and future possible crisis.

show abstract

Awareness of mental health problems in patients with coronavirus disease 19 (COVID-19): A lesson from an adult man attempting suicide

Cited by 33 publications

References 5 publications

The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis

The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis

Depression and Psychological-Behavioral Responses Among the General Public in China During the Early Stages of the COVID-19 Pandemic: Survey Study

Raising awareness of suicide prevention during the COVID‐19 pandemic

Contact Info

Product

Resources

About